Search

everythinglearnresearchcommunity

for

Search:↓

A 25-year-old Malay fireman had skin bumps on his neck that were removed successfully after other treatments failed.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

A positive anagen pull test can help detect active Lichen Planopilaris.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Minoxidil 2% effectively treats Monilethrix without side effects.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Diffuse lichen planopilaris greatly reduces quality of life.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Genetic hair shaft abnormalities can be seen with microscopes and often affect scalp hair.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Some women with common hair loss may develop permanent hair loss.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

FFA's causes may include environmental triggers and genetic factors.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.